ReP USP - Resultado da busca

Artigo de periodico
Transcranial direct current stimulation is safe and effective in autoimmune myopathies: a randomised, double-blind, sham-controlled trial (2023)
Sousa, Luiz Felipe Adsuara de; Misse, Rafael Giovane ; Santos, Lucas Macedo dos; Tanaka, Clarice ; Greve, Julia Maria D'Andrea ; Baptista, Abrahão Fontes ; Shinjo, Samuel Katsuyuki
Source: Clinical and experimental rheumatology. Unidade: FM
Subjects: ESTIMULAÇÃO MAGNÉTICA TRANSCRANIANA, MIOSITE, DOENÇAS AUTOIMUNES, ESTUDOS PROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUSA, Luiz Felipe Adsuara de et al. Transcranial direct current stimulation is safe and effective in autoimmune myopathies: a randomised, double-blind, sham-controlled trial. Clinical and experimental rheumatology, v. 41, n. 2, p. 221-229, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/53894. Acesso em: 20 maio 2024.
APA
Sousa, L. F. A. de, Misse, R. G., Santos, L. M. dos, Tanaka, C., Greve, J. M. D. 'A., Baptista, A. F., & Shinjo, S. K. (2023). Transcranial direct current stimulation is safe and effective in autoimmune myopathies: a randomised, double-blind, sham-controlled trial. Clinical and experimental rheumatology, 41( 2), 221-229. Recuperado de https://observatorio.fm.usp.br/handle/OPI/53894
NLM
Sousa LFA de, Misse RG, Santos LM dos, Tanaka C, Greve JMD'A, Baptista AF, Shinjo SK. Transcranial direct current stimulation is safe and effective in autoimmune myopathies: a randomised, double-blind, sham-controlled trial [Internet]. Clinical and experimental rheumatology. 2023 ; 41( 2): 221-229.[citado 2024 maio 20 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53894
Vancouver
Sousa LFA de, Misse RG, Santos LM dos, Tanaka C, Greve JMD'A, Baptista AF, Shinjo SK. Transcranial direct current stimulation is safe and effective in autoimmune myopathies: a randomised, double-blind, sham-controlled trial [Internet]. Clinical and experimental rheumatology. 2023 ; 41( 2): 221-229.[citado 2024 maio 20 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53894
Artigo de periodico
High prevalence of necrotising myopathy pattern in muscle biopsies of patients with anti-Jo-1 antisynthetase syndrome (2023)
Silva, Lila Morena Bueno; Borges, Isabela Bruna Pires; Shinjo, Samuel Katsuyuki
Source: Clinical and experimental rheumatology. Unidade: FM
Subjects: DOENÇAS MUSCULARES, MIOSITE, PREVALÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Lila Morena Bueno e BORGES, Isabela Bruna Pires e SHINJO, Samuel Katsuyuki. High prevalence of necrotising myopathy pattern in muscle biopsies of patients with anti-Jo-1 antisynthetase syndrome. Clinical and experimental rheumatology, v. 41, n. 2, p. 238-246, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/53775. Acesso em: 20 maio 2024.
APA
Silva, L. M. B., Borges, I. B. P., & Shinjo, S. K. (2023). High prevalence of necrotising myopathy pattern in muscle biopsies of patients with anti-Jo-1 antisynthetase syndrome. Clinical and experimental rheumatology, 41( 2), 238-246. doi:10.55563/clinexprheumatol/zq7x68
NLM
Silva LMB, Borges IBP, Shinjo SK. High prevalence of necrotising myopathy pattern in muscle biopsies of patients with anti-Jo-1 antisynthetase syndrome [Internet]. Clinical and experimental rheumatology. 2023 ; 41( 2): 238-246.[citado 2024 maio 20 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53775
Vancouver
Silva LMB, Borges IBP, Shinjo SK. High prevalence of necrotising myopathy pattern in muscle biopsies of patients with anti-Jo-1 antisynthetase syndrome [Internet]. Clinical and experimental rheumatology. 2023 ; 41( 2): 238-246.[citado 2024 maio 20 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53775
Artigo de periodico
Different clinical phenotypes in anti-melanoma differentiation-associated protein 5-associated positive dermatomyositis (2023)
Pallo, Pablo Arturo Olivo; Shinjo, Samuel Katsuyuki
Source: Clinical and experimental rheumatology. Unidade: FM
Subjects: MIOSITE, DERMATOPATIAS, AUTOANTICORPOS, DOENÇAS PULMONARES INTERSTICIAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PALLO, Pablo Arturo Olivo e SHINJO, Samuel Katsuyuki. Different clinical phenotypes in anti-melanoma differentiation-associated protein 5-associated positive dermatomyositis. Clinical and experimental rheumatology, v. 41, n. 2, p. 394-394, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/53776. Acesso em: 20 maio 2024.
APA
Pallo, P. A. O., & Shinjo, S. K. (2023). Different clinical phenotypes in anti-melanoma differentiation-associated protein 5-associated positive dermatomyositis. Clinical and experimental rheumatology, 41( 2), 394-394. Recuperado de https://observatorio.fm.usp.br/handle/OPI/53776
NLM
Pallo PAO, Shinjo SK. Different clinical phenotypes in anti-melanoma differentiation-associated protein 5-associated positive dermatomyositis [Internet]. Clinical and experimental rheumatology. 2023 ; 41( 2): 394-394.[citado 2024 maio 20 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53776
Vancouver
Pallo PAO, Shinjo SK. Different clinical phenotypes in anti-melanoma differentiation-associated protein 5-associated positive dermatomyositis [Internet]. Clinical and experimental rheumatology. 2023 ; 41( 2): 394-394.[citado 2024 maio 20 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53776
Artigo de periodico
Analysis of patient-physician discrepancy in global assessment of systemic autoimmune myopathy disease activity (2022)
Cordeiro, R. A; Fischer, F. M; Shinjo, Samuel Katsuyuki
Source: Clinical and experimental rheumatology. Unidade: FM
Subjects: DERMATOPATIAS, DOENÇAS AUTOIMUNES, MIOSITE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CORDEIRO, R. A e FISCHER, F. M e SHINJO, Samuel Katsuyuki. Analysis of patient-physician discrepancy in global assessment of systemic autoimmune myopathy disease activity. Clinical and experimental rheumatology, v. 40, n. 2, p. 339-345, 2022Tradução . . Disponível em: https://doi.org/10.55563/CLINEXPRHEUMATOL/KEIEDV. Acesso em: 20 maio 2024.
APA
Cordeiro, R. A., Fischer, F. M., & Shinjo, S. K. (2022). Analysis of patient-physician discrepancy in global assessment of systemic autoimmune myopathy disease activity. Clinical and experimental rheumatology, 40( 2), 339-345. doi:10.55563/CLINEXPRHEUMATOL/KEIEDV
NLM
Cordeiro RA, Fischer FM, Shinjo SK. Analysis of patient-physician discrepancy in global assessment of systemic autoimmune myopathy disease activity [Internet]. Clinical and experimental rheumatology. 2022 ; 40( 2): 339-345.[citado 2024 maio 20 ] Available from: https://doi.org/10.55563/CLINEXPRHEUMATOL/KEIEDV
Vancouver
Cordeiro RA, Fischer FM, Shinjo SK. Analysis of patient-physician discrepancy in global assessment of systemic autoimmune myopathy disease activity [Internet]. Clinical and experimental rheumatology. 2022 ; 40( 2): 339-345.[citado 2024 maio 20 ] Available from: https://doi.org/10.55563/CLINEXPRHEUMATOL/KEIEDV
Artigo de periodico
Feasibility, safety and efficacy of exercise training in immune-mediated necrotizing myopathies: a quasi-experimental prospective study (2019)
Souza, Jean Marcos de; Roschel, Hamilton ; Lima, Fernanda Rodrigues; Shinjo, Samuel Katsuyuki ; Oliveira, Diego Sales de; Perin, L. A; Misse, Rafael Giovane; Santos, Alexandre Moura dos; Gualano, Bruno; Sá Pinto, Ana Lucia de
Source: Clinical and experimental rheumatology. Unidades: FM, EEFE
Subjects: TREINAMENTO FÍSICO, CAPACIDADE AERÓBICA, FORÇA MUSCULAR, MIOSITE, DOENÇAS NEUROMUSCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Jean Marcos de et al. Feasibility, safety and efficacy of exercise training in immune-mediated necrotizing myopathies: a quasi-experimental prospective study. Clinical and experimental rheumatology, v. 37, n. 2, p. 235-241, 2019Tradução . . Acesso em: 20 maio 2024.
APA
Souza, J. M. de, Roschel, H., Lima, F. R., Shinjo, S. K., Oliveira, D. S. de, Perin, L. A., et al. (2019). Feasibility, safety and efficacy of exercise training in immune-mediated necrotizing myopathies: a quasi-experimental prospective study. Clinical and experimental rheumatology, 37( 2), 235-241.
NLM
Souza JM de, Roschel H, Lima FR, Shinjo SK, Oliveira DS de, Perin LA, Misse RG, Santos AM dos, Gualano B, Sá Pinto AL de. Feasibility, safety and efficacy of exercise training in immune-mediated necrotizing myopathies: a quasi-experimental prospective study. Clinical and experimental rheumatology. 2019 ; 37( 2): 235-241.[citado 2024 maio 20 ]
Vancouver
Souza JM de, Roschel H, Lima FR, Shinjo SK, Oliveira DS de, Perin LA, Misse RG, Santos AM dos, Gualano B, Sá Pinto AL de. Feasibility, safety and efficacy of exercise training in immune-mediated necrotizing myopathies: a quasi-experimental prospective study. Clinical and experimental rheumatology. 2019 ; 37( 2): 235-241.[citado 2024 maio 20 ]
Artigo de periodico
Serum interleukin-17A level is associated with disease activity of adult patients with dermatomyositis and polymyositis (2019)
Silva, M. G; Shinjo, Sueli Mieko Oba ; Marie, Suely Kazue Nagahashi ; Shinjo, Samuel Katsuyuki
Source: Clinical and experimental rheumatology. Unidade: FM
Subjects: INTERLEUCINAS, MIOSITE, DERMATOPATIAS, ESTUDOS TRANSVERSAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, M. G et al. Serum interleukin-17A level is associated with disease activity of adult patients with dermatomyositis and polymyositis. Clinical and experimental rheumatology, v. 37, n. 4, p. 656-662, 2019Tradução . . Disponível em: http://observatorio.fm.usp.br/handle/OPI/33118. Acesso em: 20 maio 2024.
APA
Silva, M. G., Shinjo, S. M. O., Marie, S. K. N., & Shinjo, S. K. (2019). Serum interleukin-17A level is associated with disease activity of adult patients with dermatomyositis and polymyositis. Clinical and experimental rheumatology, 37( 4), 656-662. Recuperado de http://observatorio.fm.usp.br/handle/OPI/33118
NLM
Silva MG, Shinjo SMO, Marie SKN, Shinjo SK. Serum interleukin-17A level is associated with disease activity of adult patients with dermatomyositis and polymyositis [Internet]. Clinical and experimental rheumatology. 2019 ; 37( 4): 656-662.[citado 2024 maio 20 ] Available from: http://observatorio.fm.usp.br/handle/OPI/33118
Vancouver
Silva MG, Shinjo SMO, Marie SKN, Shinjo SK. Serum interleukin-17A level is associated with disease activity of adult patients with dermatomyositis and polymyositis [Internet]. Clinical and experimental rheumatology. 2019 ; 37( 4): 656-662.[citado 2024 maio 20 ] Available from: http://observatorio.fm.usp.br/handle/OPI/33118
Artigo de periodico
Anti-alpha-enolase antibodies in Behcet's disease: a marker of mucocutaneous and articular disease activity? (2018)
Prado, L. L; Goncalves, C. R; Viana, V. T; Saad, C. G. S; Bonfá, Eloísa Silva Dutra de Oliveira
Source: Clinical and experimental rheumatology. Unidade: FM
Subjects: SÍNDROME DE BEHCET, BIOMARCADORES, IMUNOGLOBULINAS, ENZIMAS GLICOLÍTICAS, AUTOANTÍGENOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRADO, L. L et al. Anti-alpha-enolase antibodies in Behcet's disease: a marker of mucocutaneous and articular disease activity?. Clinical and experimental rheumatology, v. 36, n. 6, p. S28-S32, 2018Tradução . . Disponível em: http://observatorio.fm.usp.br/handle/OPI/33011. Acesso em: 20 maio 2024.
APA
Prado, L. L., Goncalves, C. R., Viana, V. T., Saad, C. G. S., & Bonfá, E. S. D. de O. (2018). Anti-alpha-enolase antibodies in Behcet's disease: a marker of mucocutaneous and articular disease activity? Clinical and experimental rheumatology, 36( 6), S28-S32. Recuperado de http://observatorio.fm.usp.br/handle/OPI/33011
NLM
Prado LL, Goncalves CR, Viana VT, Saad CGS, Bonfá ESD de O. Anti-alpha-enolase antibodies in Behcet's disease: a marker of mucocutaneous and articular disease activity? [Internet]. Clinical and experimental rheumatology. 2018 ; 36( 6): S28-S32.[citado 2024 maio 20 ] Available from: http://observatorio.fm.usp.br/handle/OPI/33011
Vancouver
Prado LL, Goncalves CR, Viana VT, Saad CGS, Bonfá ESD de O. Anti-alpha-enolase antibodies in Behcet's disease: a marker of mucocutaneous and articular disease activity? [Internet]. Clinical and experimental rheumatology. 2018 ; 36( 6): S28-S32.[citado 2024 maio 20 ] Available from: http://observatorio.fm.usp.br/handle/OPI/33011
Artigo de periodico
High prevalence of metabolic syndrome in antisynthetase syndrome (2018)
Araujo, P. A. O.; Silva, M. G.; Borba Neto, Eduardo Ferreira; Shinjo, Sueli Mieko Oba
Source: Clinical and experimental rheumatology. Unidade: FM
Subjects: ADIPOSIDADE, SÍNDROME X METABÓLICA, FATORES DE RISCO, ESTUDOS DE COORTES, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARAUJO, P. A. O. et al. High prevalence of metabolic syndrome in antisynthetase syndrome. Clinical and experimental rheumatology, v. 36, n. 2, p. 241-247, 2018Tradução . . Acesso em: 20 maio 2024.
APA
Araujo, P. A. O., Silva, M. G., Borba Neto, E. F., & Shinjo, S. M. O. (2018). High prevalence of metabolic syndrome in antisynthetase syndrome. Clinical and experimental rheumatology, 36( 2), 241-247.
NLM
Araujo PAO, Silva MG, Borba Neto EF, Shinjo SMO. High prevalence of metabolic syndrome in antisynthetase syndrome. Clinical and experimental rheumatology. 2018 ; 36( 2): 241-247.[citado 2024 maio 20 ]
Vancouver
Araujo PAO, Silva MG, Borba Neto EF, Shinjo SMO. High prevalence of metabolic syndrome in antisynthetase syndrome. Clinical and experimental rheumatology. 2018 ; 36( 2): 241-247.[citado 2024 maio 20 ]
Artigo de periodico-carta/editorial
Survival of connective tissue disease associated pulmonary arterial hypertension (2018)
Assad, A. P. Luppino; Souza, R.; Oleas, F. Gavilanes; Alves Jr., J. L.; Fernandes, C. J. C. dos Santos; Sampaia-Barros, P. D
Source: Clinical and experimental rheumatology. Unidade: FM
Subjects: HIPERTENSÃO PULMONAR, TECIDO CONJUNTIVO, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ASSAD, A. P. Luppino et al. Survival of connective tissue disease associated pulmonary arterial hypertension. Clinical and experimental rheumatology. Pisa: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 20 maio 2024. , 2018
APA
Assad, A. P. L., Souza, R., Oleas, F. G., Alves Jr., J. L., Fernandes, C. J. C. dos S., & Sampaia-Barros, P. D. (2018). Survival of connective tissue disease associated pulmonary arterial hypertension. Clinical and experimental rheumatology. Pisa: Faculdade de Medicina, Universidade de São Paulo.
NLM
Assad APL, Souza R, Oleas FG, Alves Jr. JL, Fernandes CJC dos S, Sampaia-Barros PD. Survival of connective tissue disease associated pulmonary arterial hypertension. Clinical and experimental rheumatology. 2018 ; 36( 4): S186-S186.[citado 2024 maio 20 ]
Vancouver
Assad APL, Souza R, Oleas FG, Alves Jr. JL, Fernandes CJC dos S, Sampaia-Barros PD. Survival of connective tissue disease associated pulmonary arterial hypertension. Clinical and experimental rheumatology. 2018 ; 36( 4): S186-S186.[citado 2024 maio 20 ]
Artigo de periodico
Efficacy and safety of leflunomide as an adjuvant drug in refractory dermatomyositis with primarily cutaneous activity (2017)
Souza, R. C. de; Souza, F. H. C. de; Miossi, R.; Shinjo, Sueli Mieko Oba
Source: Clinical and experimental rheumatology. Unidade: FM
Subjects: MIOSITE, FÁRMACOS IMUNOSSUPRESSORES, EVENTO ADVERSO A MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, R. C. de et al. Efficacy and safety of leflunomide as an adjuvant drug in refractory dermatomyositis with primarily cutaneous activity. Clinical and experimental rheumatology, v. 35, n. 6, p. 1011-1013, 2017Tradução . . Disponível em: http://observatorio.fm.usp.br/handle/OPI/25488. Acesso em: 20 maio 2024.
APA
Souza, R. C. de, Souza, F. H. C. de, Miossi, R., & Shinjo, S. M. O. (2017). Efficacy and safety of leflunomide as an adjuvant drug in refractory dermatomyositis with primarily cutaneous activity. Clinical and experimental rheumatology, 35( 6), 1011-1013. Recuperado de http://observatorio.fm.usp.br/handle/OPI/25488
NLM
Souza RC de, Souza FHC de, Miossi R, Shinjo SMO. Efficacy and safety of leflunomide as an adjuvant drug in refractory dermatomyositis with primarily cutaneous activity [Internet]. Clinical and experimental rheumatology. 2017 ; 35( 6): 1011-1013.[citado 2024 maio 20 ] Available from: http://observatorio.fm.usp.br/handle/OPI/25488
Vancouver
Souza RC de, Souza FHC de, Miossi R, Shinjo SMO. Efficacy and safety of leflunomide as an adjuvant drug in refractory dermatomyositis with primarily cutaneous activity [Internet]. Clinical and experimental rheumatology. 2017 ; 35( 6): 1011-1013.[citado 2024 maio 20 ] Available from: http://observatorio.fm.usp.br/handle/OPI/25488

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Subjects

Funding Agencies